IP Library Granted Patent US 9,242,936
Granted Patent B2
US 9,242,936 · App. 14/539,361 · Granted Jan 26, 2016

Methods for the preparation of charged crosslinkers

Inventors: Wei Li (Acton, MA); Robert Yongxin Zhao (Lexington, MA)
Assignee: ImmunoGen, Inc.
C07D213/71C07D207/452C07D207/46C07D401/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,242,936
App. No.
14/539,361
Granted
Jan 26, 2016
Kind
B2
Abstract

Processes for the preparation of charged crosslinkers bearing a sulfonic acid moiety are disclosed. These procedures also optionally include methods to convert the resulting products to substantially a single salt form.

Claims (50)

1. A process for the preparation of a compound of formula (III):

or a salt thereof, comprising the step of reacting a compound of formula (II):

or a salt thereof, with a sulfonating agent in the presence of a base, wherein:

Q represents a disulfide group selected from alkyl disulfide, phenyl disulfide, ortho or para-nitrophenyl disulfide, 2,4-dintrophenyl disulfide, pyridyl disulfide, nitropyridyl disulfide; a maleimido group or a haloacetyl group;

G and F are both absent;

E represents a linear or branched alkyl bearing 1 to 4 carbon atoms; and

R 1 is —H or a linear, branched or cyclic alkyl, alkenyl or alkynyl bearing 1 to 10 carbon atoms.

2. The process of claim 1 , wherein the sulfonating agent is chlorosulfonic acid or sulfur trioxide; and the base is triethyl amine, diisopropylethyl amine or tributyl amine.

3. The process of claim 1 , wherein the sulfonating agent is chlorosulfonic acid and the base is diisopropylethyl amine.

4. The process of claim 1 , wherein E is —CH 2 —CH 2 — and R 1 is H.

5. The process of claim 1 , wherein Q is pyridyl disulfide.

6. A process for the preparation of a compound of formula (IV):

or a salt thereof, comprising the step of reacting a compound of formula (2a):

or a salt thereof, with a sulfonating agent in the presence of a base.

7. The process of claim 6 , wherein the sulfonating agent is chlorosulfonic acid or sulfur trioxide and the base is triethyl amine, diisopropylethyl amine or tributyl amine.

8. The process of claim 6 , wherein the sulfonating agent is chlorosulfonic acid and the base is diisopropylethyl amine.

9. The process of claim 8 , wherein the sulfonating reaction is carried out in the presence of 1,2-di(pyridin-2-yl)disulfane (PySSPy).

10. The process of claim 9 , wherein about 0.5 equivalent of PySSPy is present.

11. The process of claim 6 , wherein the process further comprises the step of purifying the compound of formula (IV) obtained by the reaction.

12. The process of claim 11 , wherein the compound of formula (IV) is purified by reverse phase chromatography using a silica column.

13. The process of claim 1 , further comprising reacting the compound of formula (III) or a salt thereof with a hydroxy or mercapto compound to form a compound of formula (I),

or a salt thereof, wherein:

C(═O)L represents a reactive ester or thioester group selected from N-hydroxysuccinimide ester, N-hydroxy sulfosuccinimide ester, nitrophenyl ester, tetrafluoro phenyl ester, pentafluorophenyl ester, a thiopyridyl ester and a thionitrophenyl ester.

14. The process of claim 13 , wherein the reaction between the compound of formula (III) and the hydroxy or mercapto compound is carried out in the presence of a coupling agent selected from N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N,N′-diisopropyl carbodiimide (DIC) and 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

15. The process of claim 14 , wherein the coupling agent is EDC.

16. The process of claim 13 , wherein the reactive ester is N-hydroxysuccinimide ester.

17. The process of claim 13 , wherein E is —CH 2 —CH 2 — and R 1 is H.

18. The process of claim 13 , wherein Q is pyridyl disulfide.

19. A process for the preparation of a compound represented by formula (V):

or a salt thereof, comprising the steps of:

a) reacting a compound of formula (2a):

or a salt thereof, with a sulfonating agent in the presence of a base to form a compound of formula (IV):

or a salt thereof; and

b) reacting the compound of formula (IV), or a salt thereof, with N-hydroxysuccinimide to form the compound of formula (V).

20. The process of claim 19 , wherein the sulfonating agent is chlorosulfonic acid or sulfur trioxide and the base is the base is triethyl amine, diisopropylethyl amine or tributyl amine.

21. The process of claim 19 , wherein the sulfonating agent is chlorosulfonic acid and the base is diisopropylethyl amine.

22. The process of claim 21 , wherein the sulfonating reaction is carried out in the presence of PySSPy.

23. The process of claim 22 , wherein about 0.5 equivalent of PySSPy is present.

24. The process of claim 19 , wherein the reaction between the compound of formula (IV) and N-hydroxysuccinimide is carried out in the presence of a coupling agent selected from N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N,N′-diisopropyl carbodiimide (DIC) and 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

25. The process of claim 24 , wherein the coupling agent is EDC.

26. The process of claim 19 , wherein the reaction between the compound of formula (IV) and N-hydroxysuccinimide is carried in the presence of a base.

27. The process of claim 26 , wherein the base is diisopropylethylamine (DIPEA).

28. The process of claim 19 , wherein the process comprises the steps of:

a) reacting the compound of formula (2a) or a salt thereof with chlorosulfonic acid to form the compound of formula (IV); and

b) reacting the compound of formula (IV) with N-hydroxysuccinimide in the presence of EDC to form the compound of formula (V).

29. The process of claim 19 , further comprising the step of purifying the compound of formula (IV) or a salt thereof.

30. The process of claim 29 , wherein the compound of formula (IV) or a salt thereof is purified by reverse phase chromatography using a silica column.

31. The process of claim 28 , further comprising the step of purifying the compound of formula (V) or a salt thereof.

32. The process of claim 31 , wherein the compound of formula (V) or a salt thereof is purified by reverse phase chromatography using a silica column.

33. The process of claim 31 , wherein the compound of formula (V) or a salt thereof is purified by crystallization.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →
PATENT SECURITY AGREEMENT Recorded Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2015
From: LI, WEI; ZHAO, ROBERT YONGXIN
To: IMMUNOGEN, INC.
Reel/Frame 035544/0502 →
Continuity (4)
Continuation 14045151 · Oct 3, 2013
Division 13315005 · Dec 8, 2011
Provisional Application 61421357 · Dec 9, 2010
Related Publication 20150166482A1 · Jun 18, 2015